Pfizer, Sangamo partner to develop gene therapy for ALS
Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS, a disease that affects nerve cells in the brain and the spinal cord.
Wednesday, January 3, 2018
Pfizer, Sangamo partner to develop gene therapy for ALS
Pfizer, Sangamo partner to develop gene therapy for ALS
Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS, a disease that affects nerve cells in the brain and the spinal cord.
Related Posts:
Oracle paid women less than men for same work, lawsuit alleges- You can buy a house in this Italian town for about $1
- With Delta's help, Martin Luther King Jr. park in Atlanta to reopen
- These are the US cities where employees are the happiest - and most miserable
- Amazon faces strong competition from MongoDB in cloud-based database race
0 comments:
Post a Comment